{"ticker": {"uuid": "d182ff67-5fcd-48c1-9450-8975babb5883", "symbol": "EWL", "name": "Edwards Lifesciences Corporation", "exchange": "GER", "country": "DE", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Edwards Lifesciences shares may move 5% on July 23 earnings By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOaWtrbVVITG43eWt3Z1h6U3BBbFRfX002NG80UWg1QkpBUTRhMU8xY2djdDVCVzRxSVQzLThCeHU4Q0NieTFOd1hkZ3hjQlJBeFdfbC01N3AzNU44T0lHb2h4U28xYVJHMUlaVF9UZ0plclplUmZWb1Q4RWZZdGpjb3NrSWZyU0kyY3Q3UGJScVBBUE1sbTRfbTE2SEFLdEtKSDhWMlFTMXRvTXZGdnN5UGMwNmppNEU4NnpV?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-16T14:15:14+00:00", "published_display": "16 Jul 2026 14:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Daniel Lippis Sells Shares of Edwards Lifesciences Corp (EW)", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxOOWZTNGU1OFRlaU5ieTF5MENSOWZ2RHR2NXFLdHZTV08zQVFSLUlheU91UFVXX3JPX2ZJb3lOQlpJNEd2MnRPUnpWdWxyWEl1WUEtaDVwelVhWHR6TkNrcDUwd09hYlVNc25PdEpJVlJJRTlsX1N5eFFyYTllcVhERzZHamRURUw1bjhZdzlmemg1MzBoZ19vTjJFY0loOXZCbWlqNmRkcEUwdjhQNjVQOGYtX1NxbVNWdHpuZXhNMA?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-11T00:46:23+00:00", "published_display": "11 Jul 2026 00:46", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences (NYSE: EW) CVP exercises stock options and sells 619 shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOcUdQdnBkQkU0WGVIM0FIVEdQSVpaOWZ5S0V2ei1LbUpucFV1UHFJdVFEVFlHMTdYb3FkLTNUNTJ0eGZqcE4ySFlfa0NqbFZHRjlwYS05M2tsajNKNUtpVGtCb1lWQklIa0taN25ncFJ5cGxFZXFFLXgwUU5lcmNkbUV4NVVKT0tFTkxMRGNxOGpianloNVVCYWs5QW52XzB1RUNKUlpLQnQ1eGpub2QzUVhIVVk5eU41?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-10T21:04:41+00:00", "published_display": "10 Jul 2026 21:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences (EW) executive has shares withheld for tax on vesting", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOVVd0Z2J2VXllS2tFcEt3bXZuVk1UMVVnVXJnZndxZnNsamJ0Y1JmVThDSzhEbnpiU2RObjA5dTdHUWxFMjBuNE5mdmFsdDBTM0RTQlRfZW1WOHZKT3dfN1hob05NSHBrX1RCTi05WDh6VjNMVV9HT05jTk00QUwxRU5keWFfWFl4VFFXMmtLcnJ6V1hJQ19CR3NaNmxvN0V6SDM1bFZ3dlR5ZzVLd3dGTWF0M1RMMy1E?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-07T22:56:48+00:00", "published_display": "07 Jul 2026 22:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences (NYSE: EW) exec sells 619 shares under 10b5-1 plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOLU0tWE5MT21oOEJ1YlhNbzgzYTBRM0szdFkxTi0zQTdKUk9VUnI5Z0wwbW9sZHR2Z1VscTkyTE9vc1ViVHRyekRPc2g2dmpVeWstcGs0RkZVZW9UVURIQkdtZEVEVFV5ZXR1RWMwelZkXzBpNVJsUlNxTEpLUnpjaTAwRmxHY3pYQzVtNnRjNF9yaC1IVWhZa1NqOEUtaFlyN0JHNkpqblZ2Y0VkQmZfVTM4RUwyWkN2?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences presents fresh trial data, shares supported by robust S&P 500 positioning", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxPbFdDTlRDVE1lUmFxeVpzRHlIT0Fna09wWTJyOXowZTJxMUVNNzVIRmVUdEhoOFFYal9CdGYxalB0RmVHM0h1WTgxUEpHeGtGU2JKRFRwVGp0a0lXRFFvb0ZkNFpnVFU5ekRpSTVvT0cySnRNM2RGNTVFWmhfdWdXN3JBcVFTTzdVN2IzYkJnX0EwMU44WXhLcVBNMDBmTDQtTVdYSTlVWHNjMnlUelFfVjF1V3ZTaGpDZWFTaW15TzcxQzdlWFF5a19EMWk?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences stock hits 52-week high at 89.7 USD By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNOG5iMDRVSXM4aHFEZDFvSTIyclktUmxhV2ZyU3NDaUdlS1BtbzlfOEVOVk1TRkxleHBzNlQ4bVh1cWNyU1IwM3IwdkNRYWtUSlpiNkFRSl9POXRYZzh3OGFaeEtrdGN0LUMxV0gzM2cwVXBmLS1naUVHdTFCOGJxbkVqMHRVNWVTblI4cG42TWxUX1VnU2h6NlJYcGxKVjNWNzBzd3dJZmtxUy1XNi1QVmw3MGpzZw?oc=5", "source_name": "Investing.com Canada", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences (NYSE: EW) files Form 144 for proposed common sale", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOTmdDdi0xSmxpUnBkM1dJSWRJSU8wVGFwQ3VFYTNVT2hvYlNZOEpCVXRRQ1RoVUNudmtnM0RoMTBZYUMydjZieDlranMzaE9BS05YYnhoLTBJWE1mbTRxWW91bmp0RWZLWWJwUEJpX25ybFRtWnhFekFrSVBaNnZsZ29NS3BsbVNpdThqanFpT2ZtcU1xTk9vaUp5a25RaEhQY2c?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FTC moves to block Edwards Lifesciences\u2019 acquisition of JenaValve", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPSXFqNDN2c3hRckVmTTNxMWYxVk44X3A2ZnAxd0FiLW5WN21ydUNOU3U0cE9xcGQ4RklsVjFrVXFnYkFveC0tLWlVRk1tNVhBMjIyWnJhWm5EamJEUnRMMXgzYkRNcngyTnVaR3pIVEluVkt4Qnh5Y1VuYzdxYmJHUEppQlBHY3dGYklWcWZ5czRpR0h4ejE2bk5Oam4zQ3dncmRfQQ?oc=5", "source_name": "Medical Economics", "published_at": "2025-08-20T07:00:00+00:00", "published_display": "20 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences prevails in heart valve dispute at the UPC", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPRDBtWERjejZFUU5seTY4ZmFYaWNTTjNncWJOQmJSYWt5RUNUOFVUOHFmR2x5b1Y5anI3QXBDQ0pRYlUza214WjNYUExhU0FTSHNXVEFaRlBZT3l2SXZ3aHU5eUQwMHBtNF9LTXJfSWhhR09XRklTXzRsZk1ZR194RUVsbmp0bk5lRzRObXB1NDZFajZRYllxeFVaTFRUWGM?oc=5", "source_name": "JUVE Patent", "published_at": "2025-07-29T07:00:00+00:00", "published_display": "29 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences reports $14.6M in pay for CEO's first full year; median employee pay jumps", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxOay04UHBLVlNWWWZKLWZoSk1uRGdtdjdkZmNUbmxCOFFucWQxT25ZRVp3c0VpY290bVl4OXFwcTd2b0VkYUVIaXdRdERuN2FtTk1SMzJDYzQwZE1iVWdiT3ktWG4xTENrX0xxT3hweklubnVFdUhTeE1OYkFfX0tteWU3cFpmTGZwanh2WENGOXEzZWM4Q1FYSGlONE9CUk9ab2RGa0dGa1BteFhuSEsw?oc=5", "source_name": "Medical Design & Outsourcing", "published_at": "2025-04-11T07:00:00+00:00", "published_display": "11 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Epic battle over heart valves continues as EPO revokes two Edwards patents", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOT2lvT2JadEZVM2xmbGR3dTFMRURfYjZnZ180MFFuMWZacTJnd05EU29YekpfbmQtaHNubXhWbXg2dzg5ZXNuQ0Y0UTA0Mi1MbUllZmRYSXBjeDRMbzhmeEluZzgwcFdtckVBdHp0NU0xNFVTcy02Y1kwTzk5MmZ2LTEyZFdJbTVhRUp6Z09FcnJ6eXJLVDdlVHhmV2M5d1o4QlI2RlJvUExtSXdfNlE?oc=5", "source_name": "JUVE Patent", "published_at": "2025-04-04T07:00:00+00:00", "published_display": "04 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First main infringement hearing in Edwards vs Meril at Munich local division", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUTZfTHVhUEZkZ2k3OTdtMjd5RFJLWU94aWplSHFPTFg4UkV1bDRfTEpvVGNQNktmaFJfYVlIcDhQeUlWSTJVd3N1U3ZMUHhzNWdRUzBpZFY4T0ZhVTVXSnRQR2ZaS3JOcDZZLXdLeXVuTmtIUG5wZDZtSmxDRmxWam5Mc25tOFFpT3BxMXZCbnh5b1EyaW9BQmZmTFUzYjNIUm5MOGNNalEzZw?oc=5", "source_name": "JUVE Patent", "published_at": "2024-09-24T07:00:00+00:00", "published_display": "24 Sep 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences (EW) Stock Forecast and Price Target 2026 $EW", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYEFVX3lxTE1BZWo2RkN6U005VVVUdW94UGlidnA5cVJaZTZETDF0RUtwT0ZHVl8yRGxGcGR0clk2WkdlWktiUXNGZEpMRDd4bTZDdVIzTWlEWFdUN3E1UVJ0Tnc3eF9PZQ?oc=5", "source_name": "MarketBeat", "published_at": "2024-05-11T14:34:16+00:00", "published_display": "11 May 2024 14:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What's Driving Edwards Lifesciences Corp's Surprising 19% Stock Rally?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQZGtEc3ZvZTVSOEEyZC1kenhPQXlNVWNtOWRrMFZ2M0JwdUJvRmNic281NDVGbGFZSnJVeFhjclpzbFRZR3JTbS02TWdnVThrMVFRd3FHZ29pMnNLQ0ozNnlZNGJLWW00Zk5CU3Qxa195NXVtRzZpOWJaOXNON3piU1RvZ3liQXEwMlFtaS1KYUxIbDQtMGM1YURydGt1cnZ2TlpoQ0pjd0hyNkdaUjRmOFJYS1c5T2N0?oc=5", "source_name": "GuruFocus", "published_at": "2024-01-31T08:00:00+00:00", "published_display": "31 Jan 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EPO Boards of Appeal revoke Edwards Lifesciences\u2019 heart-valve patent", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOSEVnaHJQZG5jRURxUFU4VjBSdnBfbWJ6bDE1ZHBzUC0xOUlSU3JmM1VMQVJXNDhYaGRyNXVxM2w4YmhFWG9KU2JuUEhUX19LU3NhMzduR3M3MUp6UzF1dVhhMkRqX29IajRtREhCa3FmY1VvWU5HZlFCdWNVUHVGblU4eEU1aEE2c0RVaGZFZzU5T1ljUU92NW9yM3BvelFuT0s0Yw?oc=5", "source_name": "JUVE Patent", "published_at": "2023-12-05T08:00:00+00:00", "published_display": "05 Dec 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards triggers $750M share repurchase program", "summary": "", "url": "https://news.google.com/rss/articles/CBMic0FVX3lxTE01YUg0RkVBNkpjM2Yza29YWFVJc0FObVhHSzBwNHNwWnNlcHB4UkZneU5NeGo3dDN5XzdLY3dDczZ3Z0tuZ2pPdXdPaVY1S2tmblVXZlYzMVNRWjJHbVk3RGhydlFuRHF2cGRUU1RYTzJPNWc?oc=5", "source_name": "MassDevice", "published_at": "2022-11-01T07:00:00+00:00", "published_display": "01 Nov 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Edwards Lifesciences shares may move 5% on July 23 earnings By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxOaWtrbVVITG43eWt3Z1h6U3BBbFRfX002NG80UWg1QkpBUTRhMU8xY2djdDVCVzRxSVQzLThCeHU4Q0NieTFOd1hkZ3hjQlJBeFdfbC01N3AzNU44T0lHb2h4U28xYVJHMUlaVF9UZ0plclplUmZWb1Q4RWZZdGpjb3NrSWZyU0kyY3Q3UGJScVBBUE1sbTRfbTE2SEFLdEtKSDhWMlFTMXRvTXZGdnN5UGMwNmppNEU4NnpV?oc=5", "source_name": "Investing.com Nigeria", "published_at": "2026-07-16T14:15:14+00:00", "published_display": "16 Jul 2026 14:15", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Insider Sell: Daniel Lippis Sells Shares of Edwards Lifesciences Corp (EW)", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxOOWZTNGU1OFRlaU5ieTF5MENSOWZ2RHR2NXFLdHZTV08zQVFSLUlheU91UFVXX3JPX2ZJb3lOQlpJNEd2MnRPUnpWdWxyWEl1WUEtaDVwelVhWHR6TkNrcDUwd09hYlVNc25PdEpJVlJJRTlsX1N5eFFyYTllcVhERzZHamRURUw1bjhZdzlmemg1MzBoZ19vTjJFY0loOXZCbWlqNmRkcEUwdjhQNjVQOGYtX1NxbVNWdHpuZXhNMA?oc=5", "source_name": "GuruFocus", "published_at": "2026-07-11T00:46:23+00:00", "published_display": "11 Jul 2026 00:46", "sentiment": "negative", "sentiment_pct": 34, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences (NYSE: EW) CVP exercises stock options and sells 619 shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOcUdQdnBkQkU0WGVIM0FIVEdQSVpaOWZ5S0V2ei1LbUpucFV1UHFJdVFEVFlHMTdYb3FkLTNUNTJ0eGZqcE4ySFlfa0NqbFZHRjlwYS05M2tsajNKNUtpVGtCb1lWQklIa0taN25ncFJ5cGxFZXFFLXgwUU5lcmNkbUV4NVVKT0tFTkxMRGNxOGpianloNVVCYWs5QW52XzB1RUNKUlpLQnQ1eGpub2QzUVhIVVk5eU41?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-10T21:04:41+00:00", "published_display": "10 Jul 2026 21:04", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences (EW) executive has shares withheld for tax on vesting", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOVVd0Z2J2VXllS2tFcEt3bXZuVk1UMVVnVXJnZndxZnNsamJ0Y1JmVThDSzhEbnpiU2RObjA5dTdHUWxFMjBuNE5mdmFsdDBTM0RTQlRfZW1WOHZKT3dfN1hob05NSHBrX1RCTi05WDh6VjNMVV9HT05jTk00QUwxRU5keWFfWFl4VFFXMmtLcnJ6V1hJQ19CR3NaNmxvN0V6SDM1bFZ3dlR5ZzVLd3dGTWF0M1RMMy1E?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-07T22:56:48+00:00", "published_display": "07 Jul 2026 22:56", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences (NYSE: EW) exec sells 619 shares under 10b5-1 plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxOLU0tWE5MT21oOEJ1YlhNbzgzYTBRM0szdFkxTi0zQTdKUk9VUnI5Z0wwbW9sZHR2Z1VscTkyTE9vc1ViVHRyekRPc2g2dmpVeWstcGs0RkZVZW9UVURIQkdtZEVEVFV5ZXR1RWMwelZkXzBpNVJsUlNxTEpLUnpjaTAwRmxHY3pYQzVtNnRjNF9yaC1IVWhZa1NqOEUtaFlyN0JHNkpqblZ2Y0VkQmZfVTM4RUwyWkN2?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences presents fresh trial data, shares supported by robust S&P 500 positioning", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxPbFdDTlRDVE1lUmFxeVpzRHlIT0Fna09wWTJyOXowZTJxMUVNNzVIRmVUdEhoOFFYal9CdGYxalB0RmVHM0h1WTgxUEpHeGtGU2JKRFRwVGp0a0lXRFFvb0ZkNFpnVFU5ekRpSTVvT0cySnRNM2RGNTVFWmhfdWdXN3JBcVFTTzdVN2IzYkJnX0EwMU44WXhLcVBNMDBmTDQtTVdYSTlVWHNjMnlUelFfVjF1V3ZTaGpDZWFTaW15TzcxQzdlWFF5a19EMWk?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-06-28T07:00:00+00:00", "published_display": "28 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences stock hits 52-week high at 89.7 USD By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxNOG5iMDRVSXM4aHFEZDFvSTIyclktUmxhV2ZyU3NDaUdlS1BtbzlfOEVOVk1TRkxleHBzNlQ4bVh1cWNyU1IwM3IwdkNRYWtUSlpiNkFRSl9POXRYZzh3OGFaeEtrdGN0LUMxV0gzM2cwVXBmLS1naUVHdTFCOGJxbkVqMHRVNWVTblI4cG42TWxUX1VnU2h6NlJYcGxKVjNWNzBzd3dJZmtxUy1XNi1QVmw3MGpzZw?oc=5", "source_name": "Investing.com Canada", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences (NYSE: EW) files Form 144 for proposed common sale", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxOTmdDdi0xSmxpUnBkM1dJSWRJSU8wVGFwQ3VFYTNVT2hvYlNZOEpCVXRRQ1RoVUNudmtnM0RoMTBZYUMydjZieDlranMzaE9BS05YYnhoLTBJWE1mbTRxWW91bmp0RWZLWWJwUEJpX25ybFRtWnhFekFrSVBaNnZsZ29NS3BsbVNpdThqanFpT2ZtcU1xTk9vaUp5a25RaEhQY2c?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-29T07:00:00+00:00", "published_display": "29 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "FTC moves to block Edwards Lifesciences\u2019 acquisition of JenaValve", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxPSXFqNDN2c3hRckVmTTNxMWYxVk44X3A2ZnAxd0FiLW5WN21ydUNOU3U0cE9xcGQ4RklsVjFrVXFnYkFveC0tLWlVRk1tNVhBMjIyWnJhWm5EamJEUnRMMXgzYkRNcngyTnVaR3pIVEluVkt4Qnh5Y1VuYzdxYmJHUEppQlBHY3dGYklWcWZ5czRpR0h4ejE2bk5Oam4zQ3dncmRfQQ?oc=5", "source_name": "Medical Economics", "published_at": "2025-08-20T07:00:00+00:00", "published_display": "20 Aug 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences prevails in heart valve dispute at the UPC", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxPRDBtWERjejZFUU5seTY4ZmFYaWNTTjNncWJOQmJSYWt5RUNUOFVUOHFmR2x5b1Y5anI3QXBDQ0pRYlUza214WjNYUExhU0FTSHNXVEFaRlBZT3l2SXZ3aHU5eUQwMHBtNF9LTXJfSWhhR09XRklTXzRsZk1ZR194RUVsbmp0bk5lRzRObXB1NDZFajZRYllxeFVaTFRUWGM?oc=5", "source_name": "JUVE Patent", "published_at": "2025-07-29T07:00:00+00:00", "published_display": "29 Jul 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences reports $14.6M in pay for CEO's first full year; median employee pay jumps", "summary": "", "url": "https://news.google.com/rss/articles/CBMirwFBVV95cUxOay04UHBLVlNWWWZKLWZoSk1uRGdtdjdkZmNUbmxCOFFucWQxT25ZRVp3c0VpY290bVl4OXFwcTd2b0VkYUVIaXdRdERuN2FtTk1SMzJDYzQwZE1iVWdiT3ktWG4xTENrX0xxT3hweklubnVFdUhTeE1OYkFfX0tteWU3cFpmTGZwanh2WENGOXEzZWM4Q1FYSGlONE9CUk9ab2RGa0dGa1BteFhuSEsw?oc=5", "source_name": "Medical Design & Outsourcing", "published_at": "2025-04-11T07:00:00+00:00", "published_display": "11 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Epic battle over heart valves continues as EPO revokes two Edwards patents", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxOT2lvT2JadEZVM2xmbGR3dTFMRURfYjZnZ180MFFuMWZacTJnd05EU29YekpfbmQtaHNubXhWbXg2dzg5ZXNuQ0Y0UTA0Mi1MbUllZmRYSXBjeDRMbzhmeEluZzgwcFdtckVBdHp0NU0xNFVTcy02Y1kwTzk5MmZ2LTEyZFdJbTVhRUp6Z09FcnJ6eXJLVDdlVHhmV2M5d1o4QlI2RlJvUExtSXdfNlE?oc=5", "source_name": "JUVE Patent", "published_at": "2025-04-04T07:00:00+00:00", "published_display": "04 Apr 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "First main infringement hearing in Edwards vs Meril at Munich local division", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUTZfTHVhUEZkZ2k3OTdtMjd5RFJLWU94aWplSHFPTFg4UkV1bDRfTEpvVGNQNktmaFJfYVlIcDhQeUlWSTJVd3N1U3ZMUHhzNWdRUzBpZFY4T0ZhVTVXSnRQR2ZaS3JOcDZZLXdLeXVuTmtIUG5wZDZtSmxDRmxWam5Mc25tOFFpT3BxMXZCbnh5b1EyaW9BQmZmTFUzYjNIUm5MOGNNalEzZw?oc=5", "source_name": "JUVE Patent", "published_at": "2024-09-24T07:00:00+00:00", "published_display": "24 Sep 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards Lifesciences (EW) Stock Forecast and Price Target 2026 $EW", "summary": "", "url": "https://news.google.com/rss/articles/CBMiYEFVX3lxTE1BZWo2RkN6U005VVVUdW94UGlidnA5cVJaZTZETDF0RUtwT0ZHVl8yRGxGcGR0clk2WkdlWktiUXNGZEpMRDd4bTZDdVIzTWlEWFdUN3E1UVJ0Tnc3eF9PZQ?oc=5", "source_name": "MarketBeat", "published_at": "2024-05-11T14:34:16+00:00", "published_display": "11 May 2024 14:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "What's Driving Edwards Lifesciences Corp's Surprising 19% Stock Rally?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuAFBVV95cUxQZGtEc3ZvZTVSOEEyZC1kenhPQXlNVWNtOWRrMFZ2M0JwdUJvRmNic281NDVGbGFZSnJVeFhjclpzbFRZR3JTbS02TWdnVThrMVFRd3FHZ29pMnNLQ0ozNnlZNGJLWW00Zk5CU3Qxa195NXVtRzZpOWJaOXNON3piU1RvZ3liQXEwMlFtaS1KYUxIbDQtMGM1YURydGt1cnZ2TlpoQ0pjd0hyNkdaUjRmOFJYS1c5T2N0?oc=5", "source_name": "GuruFocus", "published_at": "2024-01-31T08:00:00+00:00", "published_display": "31 Jan 2024 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "EPO Boards of Appeal revoke Edwards Lifesciences\u2019 heart-valve patent", "summary": "", "url": "https://news.google.com/rss/articles/CBMipAFBVV95cUxOSEVnaHJQZG5jRURxUFU4VjBSdnBfbWJ6bDE1ZHBzUC0xOUlSU3JmM1VMQVJXNDhYaGRyNXVxM2w4YmhFWG9KU2JuUEhUX19LU3NhMzduR3M3MUp6UzF1dVhhMkRqX29IajRtREhCa3FmY1VvWU5HZlFCdWNVUHVGblU4eEU1aEE2c0RVaGZFZzU5T1ljUU92NW9yM3BvelFuT0s0Yw?oc=5", "source_name": "JUVE Patent", "published_at": "2023-12-05T08:00:00+00:00", "published_display": "05 Dec 2023 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Edwards triggers $750M share repurchase program", "summary": "", "url": "https://news.google.com/rss/articles/CBMic0FVX3lxTE01YUg0RkVBNkpjM2Yza29YWFVJc0FObVhHSzBwNHNwWnNlcHB4UkZneU5NeGo3dDN5XzdLY3dDczZ3Z0tuZ2pPdXdPaVY1S2tmblVXZlYzMVNRWjJHbVk3RGhydlFuRHF2cGRUU1RYTzJPNWc?oc=5", "source_name": "MassDevice", "published_at": "2022-11-01T07:00:00+00:00", "published_display": "01 Nov 2022 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 79, "total_relevant": 17, "sentiment_summary": {"positive": 0, "negative": 1, "neutral": 16, "score": 49, "total": 17, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 87, "events": [{"event": "general", "label": "Market update", "weight": 7.15, "count": 13}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}, {"event": "deals", "label": "Deals and strategy", "weight": 0.55, "count": 1}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}], "positive_events": 0, "negative_events": 1}, "market_context": {"has_market_context": true, "latest_close": 79.66, "latest_week": "2026-07-10", "one_week_move": -3.6, "four_week_move": 8.9, "twelve_week_move": 15.7, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.357042, "market_dynamics_buy_signal": false, "relative_strength": 9.340301, "fair_value_gap": 13.5, "fair_value_label": "Near fair-value range", "fair_value_tone": "neutral", "expectation_direction": "undecided", "expectation_probability": 50.7505, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-3.6% over one week, +8.9% over four weeks, trend active, and near fair-value range."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 62, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Stock Titan", "count": 4}, {"label": "JUVE Patent", "count": 4}, {"label": "GuruFocus", "count": 2}, {"label": "Investing.com Nigeria", "count": 1}, {"label": "ad-hoc-news.de", "count": 1}, {"label": "Investing.com Canada", "count": 1}, {"label": "Medical Economics", "count": 1}, {"label": "Medical Design & Outsourcing", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 17}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 13}, {"label": "Earnings", "count": 1}, {"label": "Deals and strategy", "count": 1}, {"label": "Guidance", "count": 1}, {"label": "Capital return", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "49/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "87/100 classification confidence."}, {"label": "Company focus", "value": "17", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-3.6% over one week, +8.9% over four weeks, trend active, and near fair-value range."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Edwards Lifesciences shares may move 5% on July 23 earnings By Investing.com"}], "updated_at": "2026-07-17T13:06:19.838313+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}